82 related articles for article (PubMed ID: 20237822)
1. Effect of loop structure of bovine lactoferricin on apoptosis in Jurkat cells.
Zhang TN; Yang W; Liu N
Biometals; 2010 Jun; 23(3):555-61. PubMed ID: 20237822
[TBL] [Abstract][Full Text] [Related]
2. Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin.
Furlong SJ; Ridgway ND; Hoskin DW
Int J Oncol; 2008 Mar; 32(3):537-44. PubMed ID: 18292930
[TBL] [Abstract][Full Text] [Related]
3. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
Furlong SJ; Mader JS; Hoskin DW
Oncol Rep; 2006 May; 15(5):1385-90. PubMed ID: 16596215
[TBL] [Abstract][Full Text] [Related]
4. Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria.
Mader JS; Richardson A; Salsman J; Top D; de Antueno R; Duncan R; Hoskin DW
Exp Cell Res; 2007 Jul; 313(12):2634-50. PubMed ID: 17570361
[TBL] [Abstract][Full Text] [Related]
5. Bovine lactoferricin induces caspase-independent apoptosis in human B-lymphoma cells and extends the survival of immune-deficient mice bearing B-lymphoma xenografts.
Furlong SJ; Mader JS; Hoskin DW
Exp Mol Pathol; 2010 Jun; 88(3):371-5. PubMed ID: 20171209
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin.
Hwang PM; Zhou N; Shan X; Arrowsmith CH; Vogel HJ
Biochemistry; 1998 Mar; 37(12):4288-98. PubMed ID: 9521752
[TBL] [Abstract][Full Text] [Related]
7. Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides.
Liu Y; Han F; Xie Y; Wang Y
Biometals; 2011 Dec; 24(6):1069-78. PubMed ID: 21607695
[TBL] [Abstract][Full Text] [Related]
8. Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines.
Mader JS; Salsman J; Conrad DM; Hoskin DW
Mol Cancer Ther; 2005 Apr; 4(4):612-24. PubMed ID: 15827335
[TBL] [Abstract][Full Text] [Related]
9. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
Farnaud S; Patel A; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
[TBL] [Abstract][Full Text] [Related]
10. A tetrameric peptide derived from bovine lactoferricin as a potential therapeutic tool for oral squamous cell carcinoma: A preclinical model.
Solarte VA; Conget P; Vernot JP; Rosas JE; Rivera ZJ; García JE; Arango-Rodríguez ML
PLoS One; 2017; 12(3):e0174707. PubMed ID: 28358840
[TBL] [Abstract][Full Text] [Related]
11. Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways.
Jiang R; Lönnerdal B
Biochem Cell Biol; 2017 Feb; 95(1):99-109. PubMed ID: 28169560
[TBL] [Abstract][Full Text] [Related]
12. Study of the interaction of lactoferricin B with phospholipid monolayers and bilayers.
Arseneault M; Bédard S; Boulet-Audet M; Pézolet M
Langmuir; 2010 Mar; 26(5):3468-78. PubMed ID: 20112931
[TBL] [Abstract][Full Text] [Related]
13. Activity and mode of action against fungal phytopathogens of bovine lactoferricin-derived peptides.
Muñoz A; Marcos JF
J Appl Microbiol; 2006 Dec; 101(6):1199-207. PubMed ID: 17105549
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a direct antitumor mechanism of action of bovine lactoferricin.
Eliassen LT; Berge G; Sveinbjørnsson B; Svendsen JS; Vorland LH; Rekdal Ø
Anticancer Res; 2002; 22(5):2703-10. PubMed ID: 12529985
[TBL] [Abstract][Full Text] [Related]
15. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin.
Nguyen LT; Schibli DJ; Vogel HJ
J Pept Sci; 2005 Jul; 11(7):379-89. PubMed ID: 15635665
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the wine spoilage yeast Dekkera bruxellensis by bovine lactoferrin-derived peptides.
Enrique M; Marcos JF; Yuste M; Martínez M; Vallés S; Manzanares P
Int J Food Microbiol; 2008 Oct; 127(3):229-34. PubMed ID: 18706729
[TBL] [Abstract][Full Text] [Related]
17. Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells.
Roy MK; Kuwabara Y; Hara K; Watanabe Y; Tamai Y
J Dairy Sci; 2002 Sep; 85(9):2065-74. PubMed ID: 12362437
[TBL] [Abstract][Full Text] [Related]
18. Interactions of bovine lactoferricin with acidic phospholipid bilayers and its antimicrobial activity as studied by solid-state NMR.
Umeyama M; Kira A; Nishimura K; Naito A
Biochim Biophys Acta; 2006 Sep; 1758(9):1523-8. PubMed ID: 16884683
[TBL] [Abstract][Full Text] [Related]
19. Anticancer activities of bovine and human lactoferricin-derived peptides.
Arias M; Hilchie AL; Haney EF; Bolscher JG; Hyndman ME; Hancock RE; Vogel HJ
Biochem Cell Biol; 2017 Feb; 95(1):91-98. PubMed ID: 28165293
[TBL] [Abstract][Full Text] [Related]
20. Requirement of the JNK-associated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukemia T cell line.
Lee SH; Park SW; Pyo CW; Yoo NK; Kim J; Choi SY
Biochimie; 2009 Jan; 91(1):102-8. PubMed ID: 18534198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
